Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Revenue (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Revenue readings, the most recent being $62.5 million for Q4 2025.

  • On a quarterly basis, Revenue fell 9.01% to $62.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $212.7 million, a 1.59% increase, with the full-year FY2025 number at $212.7 million, up 1.59% from a year prior.
  • Revenue hit $62.5 million in Q4 2025 for Treace Medical Concepts, up from $50.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $68.7 million in Q4 2024 to a low of $18.7 million in Q1 2021.
  • Median Revenue over the past 5 years was $43.3 million (2023), compared with a mean of $42.3 million.
  • Biggest five-year swings in Revenue: soared 166.88% in 2021 and later fell 9.01% in 2025.
  • Treace Medical Concepts' Revenue stood at $33.4 million in 2021, then soared by 48.84% to $49.8 million in 2022, then rose by 25.0% to $62.2 million in 2023, then rose by 10.44% to $68.7 million in 2024, then dropped by 9.01% to $62.5 million in 2025.
  • The last three reported values for Revenue were $62.5 million (Q4 2025), $50.2 million (Q3 2025), and $47.4 million (Q2 2025) per Business Quant data.